Naloxone Stocks List

Naloxone Stocks Recent News

Date Stock Title
May 3 AMPH Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
May 2 EBS Q1 2024 Emergent BioSolutions Inc Earnings Call
May 2 EBS Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
May 2 AMPH Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know
May 2 EBS Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
May 2 EBS Emergent BioSolutions gains as results top estimates, co to cut 300 jobs
May 2 EBS Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
May 2 EBS PRESS DIGEST- Wall Street Journal - May 2
May 2 EBS Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
May 2 EBS Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
May 2 EBS Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation
May 1 EBS Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
May 1 EBS Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
May 1 EBS Emergent Biosolutions Non-GAAP EPS of $0.59 beats by $1.45, revenue of $300.4M beats by $75.9M
May 1 EBS Emergent BioSolutions Reports First Quarter 2024 Financial Results
May 1 EBS Emergent BioSolutions to lay off about 300 employees
May 1 EBS UPDATE 2-Emergent BioSolutions to lay off about 300 employees
May 1 EBS Emergent BioSolutions announces reduction of about 300 employees
May 1 EBS Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
May 1 EBS Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
Naloxone

Naloxone, sold under the brandname Narcan among others, is a medication used to block the effects of opioids, especially in overdose. Naloxone may be combined with an opioid (in the same pill) to decrease the risk of opioid misuse. When given intravenously, naloxone works within two minutes, and when injected into a muscle, it works within five minutes; it may also be sprayed into the nose. The effects of naloxone last about half an hour to an hour. Multiple doses may be required, as the duration of action of most opioids is greater than that of naloxone.Administration to opioid-dependent individuals may cause symptoms of opioid withdrawal, including restlessness, agitation, nausea, vomiting, a fast heart rate, and sweating. To prevent this, small doses every few minutes can be given until the desired effect is reached. In those with previous heart disease or taking medications that negatively affect the heart, further heart problems have occurred. It appears to be safe in pregnancy, after having been given to a limited number of women. Naloxone is a non-selective and competitive opioid receptor antagonist. It works by reversing the depression of the central nervous system and respiratory system caused by opioids.Naloxone was patented in 1961 and approved for opioid overdose by the Food and Drug Administration in 1971. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. Naloxone is available as a generic medication. Its wholesale price in the developing world is between $0.50 and $5.30 per dose. Vials of naloxone are not very expensive (less than $25) in the United States. The price for a package of two auto-injectors in the US, however, has increased from $690 in 2014 to $4,500 in 2016. The 2018 price for the NHS in the United Kingdom is about £5 per dose.

Browse All Tags